A recent study demonstrated that the p38 MAPK pathway, including MKK3, is constitutively activated in B-CLL cells but not their normal peripheral B-cell counterpart [40]. The gene discussed is MAP2K3; the disease is B-cell chronic lymphocytic leukemia.